Patents Assigned to Cypress Pharmaceuticals, Inc.
  • Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
    Patent number: 10150784
    Abstract: Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable characteristics for the same. The invention further provides processes for the production of solid forms of magnesium glycinate dihydrate.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: December 11, 2018
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventor: Robert L. Lewis
  • Hyaluronate compositions
    Patent number: 9937134
    Abstract: The present invention provides compositions suitable for topical administration to a mammalian subject including sodium hyaluronate and a pharmaceutically acceptable excipient. The present invention also provides methods for making and using the same.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: April 10, 2018
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventor: Robert Lewis
  • Phosphate-binding magnesium salts and uses thereof
    Patent number: 9889157
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: February 13, 2018
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • Phosphate-binding magnesium salts and uses thereof
    Patent number: 9610267
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: April 4, 2017
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
    Patent number: 9394318
    Abstract: Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable characteristics for the same. The invention further provides processes for the production of solid forms of magnesium glycinate dihydrate.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: July 19, 2016
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventor: Robert L. Lewis
  • Phosphate-binding magnesium salts and uses thereof
    Patent number: 9339481
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: May 17, 2016
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • CRYSTAL POLYMORPH OF MAGNESIUM GLYCINATE DIHYDRATE AND PROCESS FOR ITS PREPARATION
    Publication number: 20140186408
    Abstract: Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable characteristics for the same. The invention further provides processes for the production of solid forms of magnesium glycinate dihydrate.
    Type: Application
    Filed: November 26, 2013
    Publication date: July 3, 2014
    Applicant: Cypress Pharmaceutical, Inc.
    Inventor: Robert L. Lewis
  • Hyaluronate Compositions
    Publication number: 20140057859
    Abstract: The present invention provides compositions suitable for topical administration to a mammalian subject including sodium hyaluronate and a pharmaceutically acceptable excipient. The present invention also provides methods for making and using the same.
    Type: Application
    Filed: June 12, 2013
    Publication date: February 27, 2014
    Applicant: Cypress Pharmaceuticals, Inc.
    Inventor: Robert Lewis
  • PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
    Publication number: 20140010877
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Application
    Filed: April 3, 2013
    Publication date: January 9, 2014
    Applicant: Cypress Pharmaceuticals, Inc.
    Inventor: Cypress Pharmaceuticals, Inc.
  • Hyaluronate compositions
    Patent number: 8466128
    Abstract: The present invention provides compositions suitable for topical administration to a mammalian subject including sodium hyaluronate and a pharmaceutically acceptable excipient. The present invention also provides methods for malting and using the same.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: June 18, 2013
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventor: Robert Lewis
  • PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
    Publication number: 20120282352
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Application
    Filed: July 9, 2012
    Publication date: November 8, 2012
    Applicant: CYPRESS PHARMACEUTICAL, INC.
    Inventors: Robert L. Lewis, Charles E. Day
  • PHOSPHATE-BINDING CHITOSAN AND USES THEREOF
    Publication number: 20120277183
    Abstract: The present invention provides compositions and methods for removing phosphate from a subject using chitosan. The present invention also provides compositions and methods for treating hyperphosphatemia based on phosphate-binding chitosan.
    Type: Application
    Filed: July 9, 2012
    Publication date: November 1, 2012
    Applicant: CYPRESS PHARMACEUTICAL, INC.
    Inventors: Robert L. Lewis, Charles E. Day
  • Phosphate-binding magnesium salts and uses thereof
    Patent number: 8247000
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: August 21, 2012
    Assignee: Cypress Pharmaceutical, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • Phosphate-binding magnesium salts and uses thereof
    Patent number: 8236358
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and an enteric coating.
    Type: Grant
    Filed: April 12, 2012
    Date of Patent: August 7, 2012
    Assignee: Cypress Pharmaceutical, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
    Publication number: 20120195964
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and an enteric coating.
    Type: Application
    Filed: April 12, 2012
    Publication date: August 2, 2012
    Applicant: CYPRESS PHARMACEUTICAL, INC.
    Inventors: Robert L. Lewis, Charles E. Day
  • Phosphate-binding chitosan and uses thereof
    Patent number: 7943597
    Abstract: The present invention provides compositions and methods for removing phosphate from a subject using chitosan. The present invention also provides compositions and methods for treating hyperphosphatemia based on phosphate-binding chitosan.
    Type: Grant
    Filed: April 8, 2008
    Date of Patent: May 17, 2011
    Assignee: Cypress Pharmaceutical, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
    Publication number: 20110045063
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Application
    Filed: April 10, 2009
    Publication date: February 24, 2011
    Applicant: Cypress Pharmaceutical, Inc.
    Inventors: Robert Lewis, Charles Day
  • PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
    Publication number: 20090269399
    Abstract: The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
    Type: Application
    Filed: April 10, 2009
    Publication date: October 29, 2009
    Applicant: Cypress Pharmaceutical, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • PHOSPHATE-BINDING CHITOSAN AND USES THEREOF
    Publication number: 20090253652
    Abstract: The present invention provides compositions and methods for removing phosphate from a subject using chitosan. The present invention also provides compositions and methods for treating hyperphosphatemia based on phosphate-binding chitosan.
    Type: Application
    Filed: May 6, 2009
    Publication date: October 8, 2009
    Applicant: Cypress Pharmaceutical, Inc.
    Inventors: Robert L. Lewis, Charles E. Day
  • PHOSPHATE-BINDING CHITOSAN AND USES THEREOF
    Publication number: 20080193521
    Abstract: The present invention provides compositions and methods for removing phosphate from a subject using chitosan. The present invention also provides compositions and methods for treating hyperphosphatemia based on phosphate-binding chitosan.
    Type: Application
    Filed: April 8, 2008
    Publication date: August 14, 2008
    Applicant: CYPRESS PHARMACEUTICAL, INC.
    Inventors: Robert L. Lewis, Charles E. Day